Sven Stadlbauer

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

EJNMMI radiopharmacy and chemistry

Cancers

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Albert-Ludwigs-Universität Freiburg Medizinische Fakultät

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Albert-Ludwigs-Universität Freiburg Medizinische Fakultät Jan 01 2017 - Mar 31 2018

Germany

Group leader :: Center for Complementary Medicine

European Molecular Biology Laboratory Apr 01 2012 - Dec 31 2016

Germany

Postdoctoral Researcher :: Genome Biology Unit

Tokyo Institute of Technology Apr 01 2010 - Mar 31 2012

Japan

Postdoctoral Researcher :: Department of Chemistry

Universität Leipzig May 31 2008 - Mar 31 2010

Germany

Postdoctoral Researcher :: Department of Chemistry

Publications

Fabian Krutzek, Cornelius K Donat, Sven Stadlbauer
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Fabian Krutzek, Cornelius K Donat, Sven Stadlbauer
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Fabian Krutzek, Cornelius K Donat, Sven Stadlbauer
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Sven Stadlbauer
Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1. Journal of medicinal chemistry (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Fabian Krutzek, Cornelius K Donat, Sven Stadlbauer
Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics. International journal of molecular sciences 24 (20) (2023)
Fabian Krutzek, Klaus Kopka, Sven Stadlbauer
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Thines Kanagasundaram, Markus Laube, Johanna Wodtke, Carsten Sven Kramer, Sven Stadlbauer, Jens Pietzsch, Klaus Kopka
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Anja Wacker, Ulrike Bauder-Wüst, Martin Schäfer, Jana Schmidt, Yvonne Remde, Sven Stadlbauer, Matthias Eder, Christos Liolios, Klaus Kopka
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations. Journal of labelled compounds & radiopharmaceuticals 62 (8) (2019)

Sven Stadlbauer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sven Stadlbauer